Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

NUE

Insights on NUE – Expert Analysis for Potential Investors

Now trading at a price of $259.36, Nucor has moved -2.6% so far today.

Nucor returned gains of 118.9% last year, with its stock price reaching a high of $270.9 and a low of $120.4. Over the same period, the stock outperformed the S&P 500 index by 95.7%. More recently, the company's 50-day average price was $223.58. Nucor Corporation engages in the manufacture and sale of steel and steel products. Based in Charlotte, NC, the Large-Cap Industrials company has 33,000 full time employees. Nucor has returned a 0.8% dividend yield over the last 12 months, but this may not be sustainable seen that the company has a choppy cash flow record.

Positive Cash Flows:

2020 2021 2022 2023 2024 2025
Revenue (M) $20,140 $36,484 $41,512 $34,714 $30,734 $32,494
Operating Margins 4% 25% 25% 18% 9% 8%
Net Margins 4% 19% 18% 13% 7% 5%
Net Income (M) $721 $6,827 $7,607 $4,525 $2,027 $1,744
Net Interest Expense (M) $167 $163 $219 $246 $228 $170
Depreciation & Amort. (M) $702 $735 $827 $931 $1,094 $1,226
Diluted Shares (M) 303 293 263 250 238 231
Earnings Per Share $2.36 $23.16 $28.79 $18.0 $8.46 $7.52
EPS Growth n/a 881.36% 24.31% -37.48% -53.0% -11.11%
Avg. Price $42.51 $89.84 $125.5 $174.04 $116.98 $254.39
P/E Ratio 17.94 3.87 4.35 9.64 13.81 33.78
Free Cash Flow (M) $1,154 $4,609 $8,124 $4,898 $806 -$188
CAPEX (M) $1,543 $1,622 $1,948 $2,214 $3,173 $3,422
EV / EBITDA 10.04 3.02 3.26 6.13 7.84 16.71
Total Debt (M) $5,283 $5,577 $6,642 $6,723 $6,725 $6,999
Net Debt / EBITDA 1.72 0.32 0.21 0.05 0.79 1.25
Current Ratio 3.61 2.48 3.39 3.57 2.51 2.94

Nucor has exceptional EPS growth and an excellent current ratio of 2.94. Additionally, the company's financial statements display slight revenue growth and increasing reinvestment in the business and healthy leverage levels. However, the firm has positive cash flows. Finally, we note that Nucor has decent operating margins with a negative growth trend.

Forward Earnings Expected to Increase but Priced Beyond Its Margin of Safety:

Nucor has a trailing twelve month P/E ratio of 22.2, compared to an average of 24.03 for the Industrials sector. Based on its EPS guidance of $16.56, the company has a forward P/E ratio of 13.5. According to the 32.1% compound average growth rate of Nucor's historical and projected earnings per share, the company's PEG ratio is 0.69. Taking the weighted average of the company's EPS CAGR and the broader market's 5-year projected EPS growth rate, we obtain a normalized growth rate of 17.3%. On this basis, the company's PEG ratio is 1.28. This implies that the shares are fairly valued. Additionally, the market is possibly undervaluing Nucor in terms of its equity because its P/B ratio is 2.75 whereas the sector average is 2.89. The company's shares are currently trading 109.4% below their Graham number.

There's an Analyst Consensus of Little Upside Potential for Nucor:

The 15 analysts following Nucor have set target prices ranging from $138.17 to $292.0 per share, for an average of $256.81 with a buy rating.

Nucor has an average amount of shares sold short because 2.2% of the company's shares are sold short. Institutions own 79.6% of the company's shares, and the insider ownership rate stands at 2.08%, suggesting a large amount of insider shareholders. The largest shareholder is State Farm Mutual Automobile Insurance Co, whose 11% stake in the company is worth $6,278,536,531.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS